Kalydeco (Ivacaftor)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Kalydeco (Ivacaftor), covering 2010-05-10 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation [Phase 3]